| Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals? D Granlund Social science & medicine 69 (11), 1643-1650, 2009 | 47 | 2009 |
| Are private physicians more likely to veto generic substitution of prescribed pharmaceuticals? D Granlund Social science & medicine 69 (11), 1643-1650, 2009 | 47 | 2009 |
| Price and welfare effects of a pharmaceutical substitution reform D Granlund Journal of Health Economics 29 (6), 856-865, 2010 | 40 | 2010 |
| Consumer information and pharmaceutical prices: Theory and evidence D Granlund, N Rudholm Oxford Bulletin of Economics and Statistics 73 (2), 230-254, 2011 | 26 | 2011 |
| Fixed budgets as a cost containment measure for pharmaceuticals D Granlund, N Rudholm, M Wikström The European Journal of Health Economics 7, 37-45, 2006 | 22 | 2006 |
| Parallel imports and a mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals? D Granlund, MY Koksal-Ayhan The European journal of health economics 16, 969-983, 2015 | 16 | 2015 |
| The effect of health care expenditure on sickness absence D Granlund The European Journal of Health Economics 11, 555-568, 2010 | 16 | 2010 |
| Squeezing the Last Drop Out of Your Suppliers: An Empirical Study of Market‐Based Purchasing Policies for Generic Pharmaceuticals MA Bergman, D Granlund, N Rudholm Oxford Bulletin of Economics and Statistics 79 (6), 969-996, 2017 | 15 | 2017 |
| Reforming the Swedish pharmaceuticals market: consequences for costs per defined daily dose MA Bergman, D Granlund, N Rudholm International journal of health economics and management 16, 201-214, 2016 | 13 | 2016 |
| The prescribing physician’s influence on consumer choice between medically equivalent pharmaceuticals D Granlund, N Rudholm Review of Industrial Organization 41, 207-222, 2012 | 13 | 2012 |
| Inequality in mortality in Vietnam during a period of rapid transition D Granlund, NT Chuc, HD Phuc, L Lindholm Social science & medicine 70 (2), 232-239, 2010 | 12 | 2010 |
| Price competition in pharmaceuticals–evidence from 1303 Swedish markets D Granlund, MA Bergman Journal of health economics 61, 1-12, 2018 | 11 | 2018 |
| Public goods and optimal paternalism under present-biased preferences T Aronsson, D Granlund Economics Letters 113 (1), 54-57, 2011 | 10 | 2011 |
| Apoteksmarknadens omreglering: effekter på följsamhet, priser och kostnader per dygnsdos M Bergman, D Granlund, N Rudholm Tillväxtanalys, 2012 | 9 | 2012 |
| Federal subsidization of state expenditure to reduce political budget cycles T Aronsson, D Granlund International Tax and Public Finance 24, 536-545, 2017 | 7 | 2017 |
| Consumer loyalty in the Swedish pharmaceutical market D Granlund, N Rudholm Umeå Economic Studies 742, 2008 | 7 | 2008 |
| Quantifying the zero-price effect in the field: Evidence from Swedish prescription drug choices AT Ching, D Granlund, D Sundström Journal of the Association for Consumer Research 7 (2), 175-185, 2022 | 6 | 2022 |
| Can private provision of primary care contribute to the spread of antibiotic resistance? A study of antibiotic prescription in Sweden D Granlund, YV Zykova PharmacoEconomics-Open 5, 187-195, 2021 | 6 | 2021 |
| Gender norms, work hours, and corrective taxation T Aronsson, D Granlund Journal of Behavioral and Experimental Economics 56, 33-39, 2015 | 6 | 2015 |
| Does physicians' compensation affect the probability of their vetoing generic substitution? D Granlund Handelns utredningsinstitut (HUI), 2008 | 6 | 2008 |
